Taub Foundation Grants Program for MDS Research
The Taub Foundation Grants Program for Myelodysplastic Syndromes (MDS) Research was created to support high-impact, innovative translational research to understand the underlying causes of MDS and to advance its treatment and prevention. The Program specifically focuses on MDS research, exclusive of AML and MPN. Studies focusing on molecular genetics, epigenetics, splicing factors, stem cells, the microenvironment and novel therapeutic targets relevant to MDS are encouraged.
Three-year awards of $600,000 ($200,000 per year, inclusive of 10% indirect costs) will be made to independent investigators working in non-profit, non-governmental academic, medical, or research institutions within the United States. Collaborative efforts are encouraged.
The Program is a two-step proposal process. Applicants will submit an Initial Proposal as the first step. Invited applicants will submit Full Proposals in August 2014. Funding will begin November 1, 2014. Please download the Initial Application Guidelines PDF (right) for further instruction.
Use the following links to access the Initial Online Application:
Begin a New Online Application:
Please Note: Due to scheduled maintenance, the online application will not be available from Saturday, March 8, 2014 at 10:00 pm to Sunday, March 9, 2014 at 4:00 am, US Eastern Time (ET).
Sign up for our email list to receive funding announcements for the Taub Foundation Grants Program for MDS Research.